-+ 0.00%
-+ 0.00%
-+ 0.00%

*ATyr Pharma Sees Restructuring, Other Measures Reducing Annualized Operating Expenses by $13M, Starting in 4Q

Dow Jones·08/07/2026 20:04:00

Please log in to view news